The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Digital versus manual pathology scoring of PD-L1 in patients with esophageal squamous cell carcinoma (ESCC).
 
Chunzhe Duan
Employment - Roche
Stock and Other Ownership Interests - Bristol-Myers Squibb; Roche
 
Jhe-Cyuan Guo
Honoraria - Astellas Pharma; Bayer; Ipsen; Merck Serono; MSD; Novartis; Ono Pharmaceutical; Pfizer; Roche/Genentech
Consulting or Advisory Role - Astellas Pharma; Merck Serono; Ono Pharmaceutical
Travel, Accommodations, Expenses - Ipsen; MSD; Novartis; Ono Pharmaceutical
 
Jinliang Liu
Employment - Roche
Travel, Accommodations, Expenses - Roche
 
Shijing Fu
Employment - Roche
Stock and Other Ownership Interests - Roche
 
Lizhen Wang
Employment - Roche
Stock and Other Ownership Interests - Roche
 
Chien Huai Chuang
No Relationships to Disclose
 
Stacey Huang
Employment - Roche
Stock and Other Ownership Interests - Roche
 
Tsung-Che Wu
Honoraria - Astellas Pharma; AstraZeneca; Bayer; Daiichi Sankyo; Janssen; Novartis; Roche
 
Jingyu Zhang
Employment - Roche
Stock and Other Ownership Interests - Roche
 
Chih-Hung Hsu
Honoraria - Bristol-Myers Squibb; Eisai; Merck Sharp & Dohme; Ono Pharmaceutical; Roche
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Daiichi Sankyo; Merck Serono; Ono Pharmaceutical; Roche/Genentech
Research Funding - AstraZeneca (Inst); BeiGene (Inst); Bristol-Myers Squibb (Inst); Eucure Biopharma (Inst); Ipsen (Inst); Johnson & Johnson (Inst); Merck Serono (Inst); MSD (Inst); NGM Biopharmaceuticals (Inst); Nucana (Inst); Ono Pharmaceutical (Inst); Roche/Genentech (Inst); Surface Oncology (Inst); Taiho Pharmaceutical (Inst)
Travel, Accommodations, Expenses - Daiichi Sankyo; Roche